← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2016Last known activity
Feb 26, 2025
Timeline
Drugs by trial phase (12 distinct, 7 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT06909825Lead sponsorPhase 2Feb 26, 2025
- NCT06909825OfficialPhase 2Feb 26, 2025
- NCT06402331OfficialPhase 2/Phase 3Mar 5, 2024
- NCT06402331Lead sponsorPhase 2/Phase 3Mar 5, 2024
- NCT06147037Lead sponsorPhase 1Dec 30, 2023
- NCT06147037Study directorPhase 1Dec 30, 2023
- NCT05605522Lead sponsorPhase 1Nov 30, 2022
- NCT05605522Study directorPhase 1Nov 30, 2022
- NCT05363605Lead sponsorPhase 1/Phase 2Apr 20, 2022
- NCT05363605Study directorPhase 1/Phase 2Apr 20, 2022
- NCT03746431Lead sponsorPhase 1Jan 17, 2019
- NCT02885766Lead sponsorPhase 1/Phase 2Jul 1, 2016
Details
- Founded
- Moscow, RU Jun 1, 2010
- Last known activity
- Feb 26, 2025